Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.

Saved in:
Bibliographic Details
Title: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
Authors: Mukhtar RA; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA. Rita.Mukhtar@ucsf.edu., Dimitroff K; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Yau C; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Chien AJ; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Connolly EP; Columbia University, New York, USA., Howard-McNatt M; Wake Forest, Winston-Salem, USA., Rao R; Columbia University, New York, USA., Ladores V; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Golshan M; Yale, New Haven, USA., Sauder CA; Yale, New Haven, USA.; University of California, Davis, Davis, USA., Ahmed K; H. Lee Moffitt Cancer Center, Tampa, USA., Lancaster R; University of Alabama Birmingham, Birmingham, USA., Fox J; Montefiore Medical Center, Bronx, USA., Gutnik L; University of Alabama Birmingham, Birmingham, USA., Lee MC; H. Lee Moffitt Cancer Center, Tampa, USA., Tchou J; University of Pennsylvania, Philadelphia, USA., Prionas N; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Arciero CA; Emory, Atlanta, USA., Reyna C; Loyola University, Chicago, USA., Kuerer H; MD Anderson Cancer Center, Houston, USA., Switalla K; University of Minnesota, Minneapolis, USA., Taunk N; University of Pennsylvania, Philadelphia, USA., Tuttle TM; University of Minnesota, Minneapolis, USA., Moran MS; Yale, New Haven, USA., Postlewait LM; Emory, Atlanta, USA., Perlmutter J; Gemini Group, Ann Arbor, MI, USA., DeMichele A; University of Pennsylvania, Philadelphia, USA., Yee D; University of Minnesota, Minneapolis, USA., Hylton N; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Symmans WF; MD Anderson Cancer Center, Houston, USA., Rugo HS; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Shatsky R; UC San Diego, San Diego, USA., Isaacs C; Georgetown University, Washington, USA., Esserman LJ; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Van't Veer L; UC San Francisco, 1825 4th st, San Francisco, CA, 94158, USA., Boughey JC; Mayo Clinic, Rochester, USA.
Source: Annals of surgical oncology [Ann Surg Oncol] 2025 Oct; Vol. 32 (11), pp. 8243-8253. Date of Electronic Publication: 2025 Jul 24.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1534-4681
DOI:10.1245/s10434-025-17862-0